BRILACIDIN is not out of the running yet. Still in for another government trial study that I remember when funds are available. Earlier trials showed BRILACIDIN outperformed Remdesivir by a huge factor. A lot of attention and money is going for a (maybe questionable) VACCINE and slowing down progress for TREATMENT DRUGS but TREATMENT DRUGS are just as important. maybe more so
Market Data 
Markets 
AI
